BackCalidi Biotherapeutics Overview

Calidi Biotherapeutics Accounts Payable

Track Calidi Biotherapeutics's accounts payable ($850K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$849000.00
29.13% YoYΔ $-349000.00 vs prior year quarter

Peer average

Loading

Calidi Biotherapeutics Accounts Payable History

Loading

Calidi Biotherapeutics vs. peers: Accounts Payable Comparison

Loading

Calidi Biotherapeutics Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Calidi Biotherapeutics (CLDI) FAQ

As of the most recent data (March 2026), CLDI shows a accounts payable of $850K. That compares with $1.2M in the prior-year period — down 29.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CLDI's accounts payable is now $850K (was $1.2M) — a 29.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Calidi Biotherapeutics is outperforming or lagging.

Tracking CLDI's accounts payable over time shows whether Calidi Biotherapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $850K That compares with $1.2M in the prior-year period — down 29.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Calidi Biotherapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $850K) with ownership activity and broader fundamentals.